Sign in to view content

Clinical Feasibility of Ultra-rapid, Non-pharmacologic Anesthesia for Intravitreal Injection in Patients Receiving Anti-VEGF Treatment

Cagri G Besirli, MD, PhD, FASRS

Video
Published 2018

Related

Post-Hoc Fellow Eye Analyses Support SAKURA Program Findings on Vitreous Haze, Visual Acuity and Macular Edema in Noninfectious Uveitis
Pauline T. Merrill, MD, FASRS
On Demand Cases, Courses, and Papers
2018
Economic Benefit of Higher Durability Anti-VEGF Agents in the Treatment of Neovascular Macular Degeneration
Sabin Dang, MD
Annual Meeting Talks
2023
Outcomes of Patients with DME and Baseline BCVA 20/50 or Worse or 20/40 or Better Treated with Aflibercept 8 mg and 2 mg in the Phase 2/3 PHOTON Trial
Diana V Do, MD, FASRS
Updates from the Field
2024

Category: Pharmacology

See more